Gene therapy firm AavantiBio procures $107m Series A

AavantiBio, a gene therapy company, has raised $107 million in Series A funding.

AavantiBio, a gene therapy company, has raised $107 million in Series A funding. The investors include Perceptive Advisors, Bain Capital Life Sciences and RA Capital Management.

Source: Press Release